Chronos Archive seal
The Human Record

Billie Holiday

Case HR-ML010 · Modern EHR teaching episode · Draft for review

Review summary

Historical dates
April 7, 1915 – July 17, 1959
Synthetic DOB
1993-04-07
Index visit
2026-04-20 at age 33
Synthetic MRN
HR-ML010-SYN

Teaching objective: Evidence-based, non-stigmatizing, trauma-informed primary care for a 33-year-old singer with a severe opioid use disorder and a moderate alcohol use disorder, five weeks after release from custody, when overdose risk is highest: starting buprenorphine in primary care, naloxone and overdose education, acamprosate for alcohol because naltrexone cannot be combined with buprenorphine, PEth to follow drinking, hepatitis, HIV, and liver screening with FIB-4 fibrosis staging, hepatitis A and B vaccination, depression screening with a structured safety assessment and the 988 Suicide & Crisis Lifeline, and an integrated recovery plan that continues medication through a return to use rather than requiring linear recovery, on the ASAM, SAMHSA, VA/DoD, and AASLD guidance and the CMID depression monograph.

Historical timeline

DateEventClaims
April 7, 1915Born Eleanora Fagan in Philadelphia; raised in Baltimore.CLM-0001
about 1943Began using heroin.CLM-0003
October 1945Her mother died; her drinking and drug use increased.CLM-0002
May 16, 1947Arrested for narcotics possession; sentenced to a year and a day.CLM-0004
March 16, 1948Released early from federal custody; lost her New York cabaret card.CLM-0004, CLM-0006
1950Drinking increased over the following seven years.CLM-0010
1956Lady Sings the Blues published.CLM-0008
July 17, 1959Died at Metropolitan Hospital in New York.CLM-0009

Evidence claims

D = documented, R = retrospective, S = synthetic.

GradeClaimCertaintySources
D Billie Holiday was born Eleanora Fagan in Philadelphia on April 7, 1915, and was raised in Baltimore by her mother, Sarah Julia "Sadie" Fagan. confirmed Billie Holiday supports
Billie Holiday Historical Marker supports
Nicholson S. Holiday, Billie supports
D Her mother died in October 1945; afterwards Holiday drank more heavily and her drug use increased as she grieved.
The anchor for the synthetic alcohol use disorder. The cause of her mother's death is not given in the cited sources.
confirmed Billie Holiday supports
Nicholson S. Holiday, Billie supports
Billie Holiday: About the Performer supports
D Holiday began using heroin in the early 1940s, and her addiction became severe in the late 1940s; she was arrested repeatedly over her heroin use in that period.
The anchor for the synthetic opioid use disorder. The arrests are recorded as part of her history, without judgment.
confirmed Billie Holiday: About the Performer supports
Billie Holiday supports
Nicholson S. Holiday, Billie supports
D In May 1947 Holiday was arrested for narcotics possession; she pleaded guilty, was sentenced to a year and a day, and was held at the federal facility for women at Alderson, West Virginia, until her early release on March 16, 1948.
Release after a long period of enforced abstinence carries a high risk of overdose; the modern episode begins five weeks after her release. One source names the place as "Alderston, Virginia," an evident error.
confirmed Billie Holiday Historical Marker supports
Nicholson S. Holiday, Billie supports
Billie Holiday supports
D Holiday sought treatment for her addiction, at one point checking herself into an institution in the hope of breaking her habit.
Supports her own wish to recover, which the episode builds on. The source gives no date.
confirmed Billie Holiday: About the Performer supports
D Her conviction cost her the New York City cabaret card she needed to perform in clubs that served alcohol.
A loss of income and work tied to the conviction; part of her social history.
confirmed Billie Holiday Historical Marker supports
Nicholson S. Holiday, Billie supports
Billie Holiday: About the Performer supports
R The Federal Bureau of Narcotics pursued Holiday for years, and later writers have described that pursuit as driven by racism and linked it to her performance of "Strange Fruit," a song against lynching.
Retrospective interpretation by later writers; recorded to support trauma-informed care, and not used to state any person's motives as fact.
probable Chang R. Billie Holiday and the U.S. government's war on narcotics supports
D Her autobiography, Lady Sings the Blues, written in collaboration with William Dufty, was published in 1956.
After the index date; not quoted in the record.
confirmed Billie Holiday supports
Nicholson S. Holiday, Billie supports
D In 1959 Holiday was admitted to Metropolitan Hospital in New York with liver and heart problems and was diagnosed with cirrhosis. While she was in the hospital she was arrested for narcotics possession and kept under police guard. She died there on July 17, 1959, aged 44; the cause of death is given as cirrhosis of the liver with pulmonary edema, or pulmonary edema and heart failure.
After the episode, recorded as a fact without detail. The episode records no liver diagnosis. One source dates her death to July 15, 1959.
confirmed Billie Holiday Historical Marker supports
Adams J. Lady Day departs into that good night supports
Billie Holiday supports
Billie Holiday: About the Performer supports
Nicholson S. Holiday, Billie disputes
D After 1950 she slipped deeper into alcohol use over the following seven years.
After the index date; supports the decision to treat her alcohol use from the start of the episode.
confirmed Billie Holiday: About the Performer supports

Modern synthetic problem list

GradeProblemClinical statusVerificationPlacementHistorical claims
S Opioid use disorder (heroin), severe; in early remission in a controlled environment at intake, five weeks after release from custody; on buprenorphine; synthetic modern episode linked to her documented heroin use active confirmed both_with_link CLM-0003, CLM-0004, CLM-0005
S Alcohol use disorder, moderate; synthetic modern episode linked to her documented heavier drinking after her mother's death active confirmed both_with_link CLM-0002
S Acute periapical abscess of the lower right first molar with localized swelling, treated with an antibiotic and dental drainage; resolved resolved confirmed active

Synthetic outcome measures

GradeDateMeasureResultCoding
S 2026-04-20 Hemoglobin [Mass/volume] in Blood 12.4 g/dL
Reference 11.6-15 g/dL
http://loinc.org · 718-7
S 2026-04-20 MCV [Entitic mean volume] in Red Blood Cells by Automated count 101 fL (high)
Reference 80-100 fL
http://loinc.org · 787-2
S 2026-04-20 Platelets [#/volume] in Blood by Automated count 236 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 2026-04-20 Sodium [Moles/volume] in Serum or Plasma 138 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 2026-04-20 Potassium [Moles/volume] in Serum or Plasma 4 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 2026-04-20 Creatinine [Mass/volume] in Serum or Plasma 0.72 mg/dL
Reference 0.59-1.04 mg/dL
http://loinc.org · 2160-0
S 2026-04-20 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 113 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 2026-04-20 Glucose [Mass/volume] in Serum or Plasma 88 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 2026-04-20 Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 52 U/L (high)
Reference 10-40 U/L
http://loinc.org · 1920-8
S 2026-04-20 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 38 U/L
Reference 7-56 U/L
http://loinc.org · 1742-6
S 2026-04-20 Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma 84 U/L (high)
Reference 5-40 U/L
http://loinc.org · 2324-2
S 2026-04-20 Albumin [Mass/volume] in Serum or Plasma 4 g/dL
Reference 3.5-5 g/dL
http://loinc.org · 1751-7
S 2026-04-20 Bilirubin.total [Mass/volume] in Serum or Plasma 0.7 mg/dL
Reference 0.1-1.2 mg/dL
http://loinc.org · 1975-2
S 2026-04-20 Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay 0.09
Reference Below 1.00 is nonreactive
http://loinc.org · 48159-8
S 2026-04-20 Hepatitis B virus surface Ab [Units/volume] in Serum 3 m[IU]/mL (low)
Reference >=10 m[IU]/mL
http://loinc.org · 16935-9
S 2026-04-20 Phosphatidylethanol [Mass/volume] in Blood 312 ng/mL (high)
Reference Below 20 ng/mL: abstinence or light drinking; 20 to 199: significant drinking; 200 or more: heavy drinking
http://loinc.org · 74661-0
S 2026-04-20 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 9 http://loinc.org · 44261-6
S 2026-04-20 Total score [AUDIT-C] 8 http://loinc.org · 75626-2
S 2026-04-20 Total score [DAST-10] 7 http://loinc.org · 82667-7
S 2026-05-26 Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 38 U/L
Reference 10-40 U/L
http://loinc.org · 1920-8
S 2026-05-26 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 30 U/L
Reference 7-56 U/L
http://loinc.org · 1742-6
S 2026-05-26 Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma 52 U/L (high)
Reference 5-40 U/L
http://loinc.org · 2324-2
S 2026-05-26 Phosphatidylethanol [Mass/volume] in Blood 96 ng/mL (high)
Reference Below 20 ng/mL: abstinence or light drinking; 20 to 199: significant drinking; 200 or more: heavy drinking
http://loinc.org · 74661-0
S 2026-05-26 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 7 http://loinc.org · 44261-6
S 2026-07-20 Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 44 U/L (high)
Reference 10-40 U/L
http://loinc.org · 1920-8
S 2026-07-20 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 33 U/L
Reference 7-56 U/L
http://loinc.org · 1742-6
S 2026-07-20 Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma 61 U/L (high)
Reference 5-40 U/L
http://loinc.org · 2324-2
S 2026-07-20 Phosphatidylethanol [Mass/volume] in Blood 164 ng/mL (high)
Reference Below 20 ng/mL: abstinence or light drinking; 20 to 199: significant drinking; 200 or more: heavy drinking
http://loinc.org · 74661-0
S 2026-07-20 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 11 http://loinc.org · 44261-6
S 2026-08-31 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 6 http://loinc.org · 44261-6
S 2026-08-31 Total score [AUDIT-C] 3 http://loinc.org · 75626-2
S 2026-10-19 Hemoglobin [Mass/volume] in Blood 12.9 g/dL
Reference 11.6-15 g/dL
http://loinc.org · 718-7
S 2026-10-19 MCV [Entitic mean volume] in Red Blood Cells by Automated count 95 fL
Reference 80-100 fL
http://loinc.org · 787-2
S 2026-10-19 Platelets [#/volume] in Blood by Automated count 248 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 2026-10-19 Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 30 U/L
Reference 10-40 U/L
http://loinc.org · 1920-8
S 2026-10-19 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 26 U/L
Reference 7-56 U/L
http://loinc.org · 1742-6
S 2026-10-19 Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma 34 U/L
Reference 5-40 U/L
http://loinc.org · 2324-2
S 2026-10-19 Phosphatidylethanol [Mass/volume] in Blood 22 ng/mL (high)
Reference Below 20 ng/mL: abstinence or light drinking; 20 to 199: significant drinking; 200 or more: heavy drinking
http://loinc.org · 74661-0
S 2026-10-19 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 4 http://loinc.org · 44261-6

Synthetic vital signs

DateMeasureResultLOINCGrade
2026-04-20Body height165 cm8302-2S
2026-04-20Body weight68 kg29463-7S
2026-04-20Body mass index (BMI) [Ratio]25 kg/m239156-5S
2026-04-20Systolic blood pressure126 mm[Hg]8480-6S
2026-04-20Diastolic blood pressure80 mm[Hg]8462-4S
2026-04-20Heart rate84 /min8867-4S
2026-04-20Respiratory rate16 /min9279-1S
2026-04-20Body temperature36.8 Cel8310-5S
2026-04-20Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-04-27Body height165 cm8302-2S
2026-04-27Body weight68.2 kg29463-7S
2026-04-27Body mass index (BMI) [Ratio]25.1 kg/m239156-5S
2026-04-27Systolic blood pressure122 mm[Hg]8480-6S
2026-04-27Diastolic blood pressure78 mm[Hg]8462-4S
2026-04-27Heart rate78 /min8867-4S
2026-04-27Respiratory rate14 /min9279-1S
2026-04-27Body temperature36.7 Cel8310-5S
2026-04-27Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-05-26Body height165 cm8302-2S
2026-05-26Body weight68.6 kg29463-7S
2026-05-26Body mass index (BMI) [Ratio]25.2 kg/m239156-5S
2026-05-26Systolic blood pressure118 mm[Hg]8480-6S
2026-05-26Diastolic blood pressure76 mm[Hg]8462-4S
2026-05-26Heart rate74 /min8867-4S
2026-05-26Respiratory rate14 /min9279-1S
2026-05-26Body temperature36.6 Cel8310-5S
2026-05-26Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
2026-07-20Body height165 cm8302-2S
2026-07-20Body weight67.4 kg29463-7S
2026-07-20Body mass index (BMI) [Ratio]24.8 kg/m239156-5S
2026-07-20Systolic blood pressure128 mm[Hg]8480-6S
2026-07-20Diastolic blood pressure82 mm[Hg]8462-4S
2026-07-20Heart rate86 /min8867-4S
2026-07-20Respiratory rate16 /min9279-1S
2026-07-20Body temperature36.8 Cel8310-5S
2026-07-20Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-10-19Body height165 cm8302-2S
2026-10-19Body weight69 kg29463-7S
2026-10-19Body mass index (BMI) [Ratio]25.3 kg/m239156-5S
2026-10-19Systolic blood pressure116 mm[Hg]8480-6S
2026-10-19Diastolic blood pressure74 mm[Hg]8462-4S
2026-10-19Heart rate72 /min8867-4S
2026-10-19Respiratory rate14 /min9279-1S
2026-10-19Body temperature36.6 Cel8310-5S
2026-10-19Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
2026-08-31Body height165 cm8302-2S
2026-08-31Body weight68.8 kg29463-7S
2026-08-31Body mass index (BMI) [Ratio]25.3 kg/m239156-5S
2026-08-31Systolic blood pressure118 mm[Hg]8480-6S
2026-08-31Diastolic blood pressure76 mm[Hg]8462-4S
2026-08-31Heart rate74 /min8867-4S
2026-08-31Respiratory rate14 /min9279-1S
2026-08-31Body temperature36.7 Cel8310-5S
2026-08-31Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
2026-09-21Body height165 cm8302-2S
2026-09-21Body weight68.4 kg29463-7S
2026-09-21Body mass index (BMI) [Ratio]25.1 kg/m239156-5S
2026-09-21Systolic blood pressure130 mm[Hg]8480-6S
2026-09-21Diastolic blood pressure82 mm[Hg]8462-4S
2026-09-21Heart rate92 /min8867-4S
2026-09-21Respiratory rate16 /min9279-1S
2026-09-21Body temperature37.6 Cel8310-5S
2026-09-21Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S

Social, functional, and mental status

Social history

Functional status

Mental status

Structured safety assessment

Current ideation
absent
Intent
absent
Plan
absent
Disposition
Outpatient care. Overdose risk is high in the weeks after release because tolerance has fallen: naloxone for her and her friend, never using alone, testing any drug supply with fentanyl test strips, and buprenorphine started today. The 988 Suicide & Crisis Lifeline was given and saved in her phone, and a written safety plan was made with her. Safety reviewed at every visit

This assessment is synthetic and does not convert historical behavior into a present-day fact.

Allergies and medications

Allergies

Medications

Procedures and immunizations

Procedures

Immunizations

Past medical history

True biography with historical dates; not part of the synthetic care timeline.

Family history

Care-plan goals

GoalTarget dateStatusOutcome
Stay on buprenorphine without interruption through six months, including through any return to use2026-10-19completedTaking buprenorphine 16 mg daily at six months; a three-day gap during a tour was followed by a brief return to use and an immediate restart, with no overdose
Naloxone at home and in her bag, and a friend trained to use it, by the one-week visit2026-04-27completedTwo naloxone two-packs dispensed; her friend trained
Reduce drinking to PEth below 20 ng/mL, or to the level she chooses, by six months2026-10-19completedPEth 22 ng/mL from 312; occasional light drinking, which she chose
Hepatitis A and B vaccine series completed by six months2026-10-19completedHepatitis B doses at intake and five weeks; hepatitis A doses at intake and six months
PHQ-9 score below 5 by six months2026-10-19completedPHQ-9 4

Interventions

InterventionStatusGuideline
Buprenorphine with naloxone started in primary care at a low first dose, then 16 mg daily, continued through any return to use; naloxone, overdose education, never using alone, and fentanyl test stripscompletedGL-ASAM-OUD-2020, GL-SAMHSA-MOUD, GL-SUD-2021
Addiction medicine consultation to confirm the medication plan, choose a medicine for alcohol use disorder that can be used with buprenorphine, and set the monitoring plancompletedGL-ASAM-OUD-2020, GL-SUD-2021
Alcohol care: acamprosate, thiamine, brief counseling and goals she chooses, and PEth at each check to follow drinking without relying on memorycompletedGL-SUD-2021, GL-SAMHSA-MOUD
Liver and infection screening: liver tests and FIB-4 at intake and six months, hepatitis C antibody, hepatitis B triple panel, and HIV test, with hepatitis A and B vaccines for a person who is not immunecompletedGL-AASLD-ALD-2019, GL-AASLD-NIT-2025, GL-CDC-HBV-2023, GL-USPSTF-HCV-2020, GL-USPSTF-HIV-2019
Depression screening with the PHQ-9 at each recovery visit, a structured safety assessment with a written safety plan and the 988 Suicide & Crisis Lifeline, and safety review at every visitcompletedGL-CMID-2026, GL-USPSTF-DEP-2023, GL-SUICIDE-2024
Integrated, trauma-informed recovery plan: weekly counseling, a peer recovery coach, confidentiality she controls, and a written plan for touring, without requiring recovery to be perfect or linearcompletedGL-SUD-2021, GL-SAMHSA-MOUD

Planned encounters

Supporting documents

C-CDA note documents

Each link opens a readable copy; the XML beside it is the exchange file.

Sources

IDSourcePublisherType
SRC-0001 Billie Holiday: About the Performer PBS American Masters (WNET) other
SRC-0002 Billie Holiday Biography.com (A&E Television Networks) other
SRC-0003 Billie Holiday Historical Marker Clio (African American History of Philadelphia Heritage Trail, Saint Vincent College) scholarly
SRC-0004 Nicholson S. Holiday, Billie Jazz.com encyclopedia other
SRC-0005 Chang R. Billie Holiday and the U.S. government's war on narcotics Biography.com (A&E Television Networks) other
SRC-0006 Adams J. Lady Day departs into that good night The Globe and Mail other
SRC-0007 HISTMED Master Roster v3 The Human Record project other

Review status

ReviewStatusNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check the low first buprenorphine dose after enforced abstinence, acamprosate rather than naltrexone, and the FIB-4 interpretation.
provenance reviewnot_startedPBS American Masters, Biography.com, Clio (Saint Vincent College), the Jazz.com encyclopedia, and The Globe and Mail logged. The account of racially motivated targeting is graded R. Her autobiography was not fetched and is not quoted.
safe messaging reviewnot_startedSubstance-use claims are marked sensitive; person-first language throughout; arrests and custody recorded without judgment and never as her fault; the return to use is managed without blame or discharge; the safety assessment gives the 988 Suicide & Crisis Lifeline; death recorded without detail.

Comments and corrections

Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.

Comments appear on the online version of this page.